Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Idracare is a non-hormonal vaginal moisturizing gel developed by Procare Health, specifically formulated to address vaginal dryness and atrophy. The product utilizes niosomal technology to deliver a high concentration of hyaluronic acid into the deeper layers of the vaginal epithelium, promoting tissue hydration and elasticity. In addition to hyaluronic acid, the gel contains Aloe Vera for its soothing and restorative properties and Bioecolia, a prebiotic that supports the health of the vaginal microbiota. It is indicated for women experiencing decreased vaginal secretion due to various factors, including menopause, postpartum recovery, breastfeeding, radiotherapy, or the use of hormonal contraceptives. It is marketed as a medical device and is typically applied twice a week.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Idracare.